Search results
Results from the WOW.Com Content Network
Founded in 2005, Parsemus is an advocate of research into the plausibility of RISUG (and a method based on RISUG, called Vasalgel), a reversible male contraceptive. [2] [3] The foundation began procuring RISUG's United States intellectual property rights in November 2010, completed the acquisition process in February 2012, and is for the past 8 years conducting toxicology tests as an initial ...
Diagram showing the site of injection of the product Vasalgel, a vasectomy alternative. Reversible inhibition of sperm under guidance (RISUG), formerly referred to as the synthetic polymer styrene maleic anhydride (SMA), is the development name of a male contraceptive injection developed at IIT Kharagpur in India by the team of Dr. Sujoy K. Guha.
Vasalgel was successful in achieving azoospermia in rabbits within 36 days of injection, as well as returned vas deferens patency. [9] In 2023, the patent for Vasalgel was acquired by NEXT Life Sciences , Inc., which plans to bring the technology to market under the name Plan A for Men .
If the Food and Drug Administration approves the gel, Whitehead said he would definitely keep using it, especially after watching his partner struggle with available female birth control options.
For premium support please call: 800-290-4726 more ways to reach us
The list, which includes 15 drugs, up from 10 last year, is the first step in a negotiation process between Medicare and drugmakers that is expected to take place over the coming months. The new ...
What links here; Related changes; Upload file; Special pages; Permanent link; Page information; Cite this page; Get shortened URL; Download QR code
MORE: Details of what's in the ceasefire deal between Israel and Hamas. The identities of all the hostages being released by Hamas and Israel have yet to be made public.